These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32294173)
1. Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo. Pearce C; Ruth MM; Pennings LJ; Wertheim HFL; Walz A; Hoefsloot W; Ruesen C; Muñoz Gutiérrez J; Gonzalez-Juarrero M; van Ingen J J Antimicrob Chemother; 2020 Jul; 75(7):1889-1894. PubMed ID: 32294173 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of Short-Term Tigecycline-Containing Regimens for Mycobacterium abscessus Pulmonary Disease. Kim SR; Jang M; Kim SY; Kim DH; Jhun BW Antimicrob Agents Chemother; 2022 Oct; 66(10):e0077422. PubMed ID: 36165626 [TBL] [Abstract][Full Text] [Related]
3. Activity of Oritavancin and Its Synergy with Other Antibiotics against Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513 [TBL] [Abstract][Full Text] [Related]
4. Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus. Bax HI; de Vogel CP; Mouton JW; de Steenwinkel JEM J Antimicrob Chemother; 2019 Oct; 74(10):2930-2933. PubMed ID: 31236595 [TBL] [Abstract][Full Text] [Related]
5. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination. Pryjma M; Burian J; Thompson CJ Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147 [No Abstract] [Full Text] [Related]
6. Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. Myojin S; Fukuoka K; Kanemaru A; Baba S; Okamoto Y; Suzuki H; Kamada K; Yoshida A; Kikuchi K; Horikoshi Y Int J Infect Dis; 2018 Sep; 74():10-12. PubMed ID: 29966711 [TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease. Choi H; Kim SY; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin S; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739795 [TBL] [Abstract][Full Text] [Related]
14. Ex vivo infection of murine precision-cut lung tissue slices with Mycobacterium abscessus: a model to study antimycobacterial agents. Molina-Torres CA; Flores-Castillo ON; Carranza-Torres IE; Guzmán-Delgado NE; Viveros-Valdez E; Vera-Cabrera L; Ocampo-Candiani J; Verde-Star J; Castro-Garza J; Carranza-Rosales P Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):52. PubMed ID: 33222688 [TBL] [Abstract][Full Text] [Related]
15. Improved Clinical Outcome After Treatment of Mycobacterium abscessus Complex Pulmonary Disease in Children With Cystic Fibrosis. Chacko A; Wen SCH; Hartel G; Kapur N; Wainwright CE; Clark JE Pediatr Infect Dis J; 2019 Jul; 38(7):660-666. PubMed ID: 30724835 [TBL] [Abstract][Full Text] [Related]
16. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865 [TBL] [Abstract][Full Text] [Related]
17. Epetraborole Is Active against Mycobacterium abscessus. Ganapathy US; Gengenbacher M; Dick T Antimicrob Agents Chemother; 2021 Sep; 65(10):e0115621. PubMed ID: 34280020 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of tedizolid against the Mycobacterium abscessus complex. Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419 [TBL] [Abstract][Full Text] [Related]
19. Synergistic Efficacy of β-Lactam Combinations against Story-Roller E; Maggioncalda EC; Lamichhane G Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979 [No Abstract] [Full Text] [Related]
20. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series. Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]